This clinical quiz, our last in a series of 4, focuses on recommendations for special populations and long-term management from the 2020 ACR gout guidelines.
Gout is a growing public health burden that impacts approximately 4% of US adults, with a prevalence that has more than doubled from the 1960s and is expected to continue to rise in the coming decades.1,2
Gout requires careful management to maintain quality of life and there are many factors for rheumatologists to take into account when treating patients with gout and particular considerations for people with comorbidities, as gout is a chronic disease that must be monitored and managed long-term.
In 2020, the American College of Rheumatology (ACR) issued new guidance and recommendations for the management of gout. The 17-page document, which was the group's first new guideline on the topic since 2012, contained 42 recommendations, including 16 strong recommendations. In this clinical quiz, the third in a series of 4 based on the guideline, we test your knowledge on the management of gout flares.3
True or False: In patients with chronic kidney disease, febuxostat is preferred over allopurinol for ULT.
Check out other quizzes on the 2020 ACR gout guidelines:
Initiation and titration of urate-lowering therapy
Clinical Quiz: Lifestyle and Comorbidities from 2020 ACR Gout Guidelines
References: